Pharmacokinetic, pharmacodynamic, and pharmacogenetic determinants of osteonecrosis in children with acute lymphoblastic leukemia
Jitesh D. Kawedia(The University of Texas MD Anderson Cancer Center), Mary V. Relling(St. Jude Children's Research Hospital), Ching‐Hon Pui(St. Jude Children's Research Hospital), William E. Evans(St. Jude Children's Research Hospital), John C. Panetta(St. Jude Children's Research Hospital), Cheng Cheng(St. Jude Children's Research Hospital), Xiangjun Cai(Shenyang 242 Hospital), Sue C. Kaste(St. Jude Children's Research Hospital), Geoffrey Neale(St. Jude Children's Research Hospital), Deqing Pei(St. Jude Children's Research Hospital), Scott C. Howard(Hospital Sant Joan de Déu Barcelona)
Cited by 259
Related Papers
International Consensus Classification of Myeloid Neoplasms and Acute Leukemias: integrating morphologic, clinical, and genomic data
|Blood|2022|2.8k
Treatment of Acute Lymphoblastic Leukemia
|New England Journal of Medicine|2006|2k